Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis: A Case Series

No abstract available
Source: JCR: Journal of Clinical Rheumatology - Category: Rheumatology Tags: Concise Reports Source Type: research